Recent Updates
Recently added Catalysts
IDYA Positive Sentiment Score: 60/100

IDEAYA Biosciences to Participate in Citi's 2023 Virtual Oncology Leadership Summit IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development ...

Key Takeaway: IDEAYA Biosciences, Inc. will participate in Citi's 2023 Virtual Oncology Leadership Summit, featuring a fireside chat with CEO Yujiro S. Hata. The event is scheduled for February 21, 2023, and will be accessible through a live audio webcast on IDEAYA's website. A replay of the event will also be available for 30 days post-event. This participation highlights IDEAYA's commitment to advancing its presence in the oncology sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • IDEAYA Biosciences is participating in a significant oncology leadership summit.
  • The event will feature a fireside chat with the CEO, enhancing visibility.
  • A live audio webcast will allow broader access to the discussion.

Full Press Release Details

Citi's 2023 Virtual Oncology Leadership Summit Tuesday, February 21, 2023 at 9:00 AM ET ( 6:00 AM PT ) Fireside chat with Yujiro S. Hata , President and Chief Executive Officer, hosted by Yigal D. Nochomovitz , Ph.D., Director, SMid Cap Biotech Analyst.
A live audio webcast of the event will be available, as permitted by conference host, at the "Investors/ Events" section of the IDEAYA website at https://ir.ideayabio.com/events . A replay of the webcast will be accessible for 30 days following the live event.
About IDEAYA Biosciences
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's Quarterly Report on Form 10-Q filed on November 8, 2022 and any current and periodic reports filed with the U.S. Securities and Exchange Commission.
Investor and Media Contact IDEAYA Biosciences Paul Stone Senior Vice President and Chief Financial Officer [email protected]
SOURCE IDEAYA Biosciences, Inc.

21 %

Frequently Asked Questions

When is Citi's 2023 Virtual Oncology Leadership Summit?

The summit is on February 21, 2023, at 9:00 AM ET.

Who will host the fireside chat at the event?

The fireside chat will be hosted by Yigal D. Nochomovitz, Ph.D.

How can I access the event webcast?

The live audio webcast will be available in the 'Investors/Events' section on the IDEAYA website.

Will a replay of the summit be available?

Yes, a replay of the webcast will be accessible for 30 days after the event.

Last updated: Feb 16, 2023